You have 9 free searches left this month | to do more
Showing 1 - 25 of
1,809 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer
Recruiting
  • Recurrent Head and Neck Cancer
  • Ad/PNP
  • Fludarabine Phosphate
  • Stanford, California
    Stanford University
2022-03-23
Mar 23, 2022
C
Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • fludarabine phosphate
  • +3 more
  • Duarte, California
    City of Hope Medical Center
2022-02-28
Feb 28, 2022
M
Venetoclax and Sequential Busulfan, Cladribine, and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-18
Nov 18, 2021
C
Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Duarte, California
    City of Hope Medical Center
2021-11-02
Nov 2, 2021
M
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) - 2020
Completed
Has Results
  • Disorder Related to Bone Marrow Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-18
Nov 18, 2021
M
Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-06
Jan 6, 2022
S
A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors
Recruiting
  • Hematological Malignancies
  • Total Body Irradiation
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2022-02-04
Feb 4, 2022
M
Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances
Not yet recruiting
  • Hematological Malignancy
  • Fludarabine Phosphate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-26
Oct 26, 2021
M
Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies
Active, not recruiting
  • B-Lymphoid Malignancies
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-18
Nov 18, 2021
M
MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
Recruiting
  • Epidermolysis Bullosa
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center and Medical Center
2022-01-20
Jan 20, 2022
M
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Not yet recruiting
  • B-Cell Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-08
Mar 8, 2022
M
Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma - 2021
Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-02-15
Feb 15, 2021
M
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)
Recruiting
  • Colon Cancer
  • Resected Stage
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-14
Mar 14, 2022
M
Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia - 2020
Completed
Has Results
  • Fanconi Anemia
  • anti-thymocyte globulin
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
2021-11-04
Nov 4, 2021
C
Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma
Active, not recruiting
  • Autologous Hematopoietic Stem Cell Transplant Recipient
  • +4 more
  • Duarte, California
    City of Hope
2022-03-17
Mar 17, 2022
N
Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL
Active, not recruiting
Has Results
  • Small Lymphocytic Lymphoma
  • CLL (Chronic Lymphocytic Leukemia)
  • Fludarabine Phosphate
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-06
Apr 6, 2022
C
Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
Withdrawn
  • Leukemia
  • Lymphoma
  • rituximab
  • +2 more
  • Seattle, Washington
    Cell Therapeutics, Incorporated
2020-10-14
Oct 14, 2020
M
Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-14
Feb 14, 2022
M
Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma
Active, not recruiting
  • Melanoma
  • Dendritic Cell Immunization
  • +7 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
2021-07-30
Jul 30, 2021
M
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin - 2012
Completed
Has Results
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
2020-09-22
Sep 22, 2020
U
Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant
Recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +3 more
  • Fludarabine Phosphate
  • +9 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
2022-01-07
Jan 7, 2022
I
ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma
Recruiting
  • Malignant Melanoma
  • Herlev, Denmark
    National Center for Cancer Immune Therapy (CCIT-DK)
2021-09-14
Sep 14, 2021
C
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies - 2020
Completed
  • Acute Myeloid Leukemia
  • +10 more
  • total marrow irradiation
  • +7 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
2021-05-05
May 5, 2021
F
Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma - 2021
Completed
  • Stage III Cutaneous Melanoma AJCC v7
  • +5 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-01-03
Jan 3, 2022
F
Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders - 2020
Completed
Has Results
  • Non-Neoplastic Hematologic and Lymphocytic Disorder
  • Allogeneic Bone Marrow Transplantation
  • +11 more
  • Aurora, Colorado
  • +5 more
2021-07-21
Jul 21, 2021